Cargando…

PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107

Detalles Bibliográficos
Autores principales: Ilan, Uri, Boer, Judith M., Burkhardt, Birgit, van Delft, Frederik, Izraeli, Shai, Klusmann, Jan-Henning, Moerloose, Barbara De, Velasco, Pablo, Irving, Julie, Fuster, José Luis, Erdélyi, Dániel, Kulozik, Andreas E, Reinhardt, Dirk, Zwaan, Michel, den Boer, Monique L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430021/
http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6
_version_ 1785090853919784960
author Ilan, Uri
Boer, Judith M.
Burkhardt, Birgit
van Delft, Frederik
Izraeli, Shai
Klusmann, Jan-Henning
Moerloose, Barbara De
Velasco, Pablo
Irving, Julie
Fuster, José Luis
Erdélyi, Dániel
Kulozik, Andreas E
Reinhardt, Dirk
Zwaan, Michel
den Boer, Monique L.
author_facet Ilan, Uri
Boer, Judith M.
Burkhardt, Birgit
van Delft, Frederik
Izraeli, Shai
Klusmann, Jan-Henning
Moerloose, Barbara De
Velasco, Pablo
Irving, Julie
Fuster, José Luis
Erdélyi, Dániel
Kulozik, Andreas E
Reinhardt, Dirk
Zwaan, Michel
den Boer, Monique L.
author_sort Ilan, Uri
collection PubMed
description
format Online
Article
Text
id pubmed-10430021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104300212023-08-17 PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107 Ilan, Uri Boer, Judith M. Burkhardt, Birgit van Delft, Frederik Izraeli, Shai Klusmann, Jan-Henning Moerloose, Barbara De Velasco, Pablo Irving, Julie Fuster, José Luis Erdélyi, Dániel Kulozik, Andreas E Reinhardt, Dirk Zwaan, Michel den Boer, Monique L. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430021/ http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Ilan, Uri
Boer, Judith M.
Burkhardt, Birgit
van Delft, Frederik
Izraeli, Shai
Klusmann, Jan-Henning
Moerloose, Barbara De
Velasco, Pablo
Irving, Julie
Fuster, José Luis
Erdélyi, Dániel
Kulozik, Andreas E
Reinhardt, Dirk
Zwaan, Michel
den Boer, Monique L.
PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title_full PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title_fullStr PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title_full_unstemmed PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title_short PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
title_sort pb1725: international leukemia target board - a platform to discuss and prioritize targeted treatment options for patients with relapsed/refractory pediatric hematological malignancies (iltb) – itcc 107
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430021/
http://dx.doi.org/10.1097/01.HS9.0000973760.86945.e6
work_keys_str_mv AT ilanuri pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT boerjudithm pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT burkhardtbirgit pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT vandelftfrederik pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT izraelishai pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT klusmannjanhenning pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT moerloosebarbarade pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT velascopablo pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT irvingjulie pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT fusterjoseluis pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT erdelyidaniel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT kulozikandrease pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT reinhardtdirk pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT zwaanmichel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107
AT denboermoniquel pb1725internationalleukemiatargetboardaplatformtodiscussandprioritizetargetedtreatmentoptionsforpatientswithrelapsedrefractorypediatrichematologicalmalignanciesiltbitcc107